Stock market week-in-review for 5 large GI companies — Sept. 25-29

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Sept. 25 to Sept. 29, 2017.

Advertisement

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $204.61 on Sept. 25
Peaked: $216.40 on Sept. 26
Closed: $204.89 on Sept. 29
Percent change between Sept. 25 and Sept. 29: 0.13 percent

2. Exact Sciences Corp.

Opened: $45.96 on Sept. 25
Peaked: $47.50 on Sept. 28
Closed: $47.12 on Sept. 29
Percent change between Sept. 25 and Sept. 29: 2.52 percent

3. Johnson & Johnson

Opened: $131.20 on Sept, 25
Peaked: $131.93 on Sept. 26
Closed: $129.84 on Sept. 29
Percent change between Sept. 25 and Sept. 29: -1.03 percent

4. Synergy Pharmaceuticals

Opened: $2.59 on Sept. 25
Peaked: $2.93 on Sept. 29
Closed: $2.90 on Sept. 29
Percent change between Sept. 25 and Sept. 29: 11.96 percent

5. Valeant Pharmaceuticals

Opened: $13.96 on Sept. 25
Peaked: $14.51 on Sept. 29
Closed: $14.33 on Sept. 29
Percent change between Sept. 25 and Sept. 29: 2.65 percent

More articles on gastroenterology: 
GI leader to know: Dr. Benigno Varela of Gastroenterology Center of Connecticut
Massachusetts medical center removing GI endoscopy unit from ASC — 3 insights
Valeant sells iNova Pharmaceuticals for $930M — 4 insights

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.